MoFo News Item

Morrison & Foerster Launches Life Sciences Blog, MoFo Life Sciences

22 May 2019

Morrison & Foerster is proud to announce the launch of its newest blog, MoFo Life Sciences, which can be accessed at The firm has started this cross-practice, cross-jurisdictional blog to help its clients stay on top of the trends, politics, laws, cases, and economic drivers in the ever-changing life sciences industry around the world.

MoFo Life Sciences shares timely legal and business insights and in-depth analyses on trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, data analytics, diagnostics, medical devices, digital health, and AgTech fields in the U.S., Europe and Asia. The blog will feature insights from Morrison & Foerster’s attorneys across many practices and jurisdictions, including Intellectual Property, Corporate, Licensing, Litigation, Regulatory, Product Liability and Class Action, Privacy & Data Security, and AI & Robotics.

Upcoming and previous content on the blog includes artificial intelligence and life sciences, patent eligibility in life sciences, the interplay between EU clinical trials regulation and GDPR, Hatch-Waxman and BPCIA developments, what life sciences companies and investors need to know about CFIUS, and much more.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.